March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Raver2: A Novel Regulator Of sFlt1 Production
Author Affiliations & Notes
  • Derick G. Holt
    Ophthal & Visual Sciences,
    University of Utah, Salt Lake City, Utah
  • Subrata K. Das
    Ophthalmology, Moran Eye Center, Salt Lake City, Utah
  • Wei Huang
    University of Utah, Salt Lake City, Utah
  • Balamurali K. Ambati
    Ophthalmology, John Moran Eye Center, Salt Lake City, Utah
  • Footnotes
    Commercial Relationships  Derick G. Holt, None; Subrata K. Das, None; Wei Huang, None; Balamurali K. Ambati, None
  • Footnotes
    Support  NIH Grant 5R01EY01795003
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2390. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Derick G. Holt, Subrata K. Das, Wei Huang, Balamurali K. Ambati; Raver2: A Novel Regulator Of sFlt1 Production. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2390.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Pathologic neovascularization (NV) underlies several sight-threatening ocular diseases. VEGF is a key regulator of angiogenesis and misregulation of VEGF signaling has been implicated in the pathophysiology of NV. Our previous work has shown that the soluble isoform of tyrosine kinase receptor Flt1 (sFlt1) plays a critical role in preserving avascularity in the cornea and outer retina, and that disruption of endogenous sFlt1 can recapitulate certain human NV disease states. sFlt1 production relies upon a specific form of alternative RNA processing known as intronic polyA activation (IPA). In this study, we investigate the molecular mechanisms underlying this key RNA processing event.

Methods: : siRNA knock-down was done via corneal plasmid injection and transfection into HUVEC cultures. mRNA expression levels were assayed by RT-PCR, and protein levels determined by Western and ELISA. Molecular associations were investigated via standard immunoprecipitation (IP) methods, including co-IP and RNA IP (RIP).

Results: : Prior microarray analyses identified Raver2 as a factor whose expression profile mirrored that of sFlt1, suggesting that it might promote sFlt1 production. Indeed, knock-down of Raver2 correlated with significantly decreased sFlt1 levels both in vivo (mouse cornea) and in vitro (HUVEC cells). We also observed marked corneal NV following Raver2 knock-down in WT mice. Given the functional importance of Raver2, we sought to determine if the factor acted at the level of Flt1 pre-mRNA. RIP experiments showed robust enrichment of Flt1 RNA, implicating a direct association of Raver2 with Flt1 pre-mRNA. To further characterize Raver2 function, IP of cellular extracts was performed, which showed specific enrichment for PTB, a well-studied factor involved in alternative splicing and polyadenylation. RIP for PTB also enriched Flt1 RNA, and RIP following Raver2 knock-down showed significantly reduced PTB occupancy.

Conclusions: : We identify for the first time a specific endogenous factor, Raver2, which promotes sFlt1 production. Furthermore, we demonstrate that Raver2 and PTB localize to Flt1 pre-mRNA and provide evidence that Raver2 promotes PTB association with Flt1 pre-mRNA. Taken together, our data suggest a model in which Raver2-mediated recruitment of PTB promotes specific IPA resulting in expression of the sFlt1 isoform.

Keywords: cornea: basic science • vascular endothelial growth factor • gene/expression 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.